Skip to main content
. 2019 May 23;1(4):236–243. doi: 10.1002/acr2.1025

Figure 5.

Figure 5

Time to complete response for patients who responded to administration of pegloticase every 4 weeks. Complete response was achieved by 16 (64%) of 24 patients, with 50% achieving this response in 424 days. RCT, randomized controlled trial.